Drug Shortage Report for VEPESID
| Report ID | 70228 |
| Drug Identification Number | 00616192 |
| Brand name | VEPESID |
| Common or Proper name | Etoposide |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | ETOPOSIDE |
| Strength(s) | 50MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 1 BTL x 20 |
| ATC code | L01CB |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2019-07-01 |
| Actual start date | |
| Estimated end date | 2019-07-01 |
| Actual end date | 2019-07-01 |
| Shortage status | Resolved |
| Updated date | 2019-07-05 |
| Company comments | Stock is being allocated. Generics on back order for Etoposide IV has increased demand for Vepesid capsules. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-12-20 | English | Compare |